本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mersana Therapeutics Inc.

0.3269
-0.0278-7.84%
盘后0.34320.0163+4.99%16:06 EDT
成交量:232.59万
成交额:80.27万
市值:4,074.20万
市盈率:-0.58
高:0.3640
开:0.3430
低:0.3262
收:0.3547
数据加载中...
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]